Literature DB >> 19107587

An analysis of electronically monitored adherence to antiretroviral medications.

George J Knafl1, Carol A Bova, Kristopher P Fennie, Jean P O'Malley, Kevin D Dieckhaus, Ann B Williams.   

Abstract

Medication adherence studies increasingly collect data electronically, often using Medication Event Monitoring System (MEMS) caps. Analyses typically focus on summary adherence measures, although more complete analyses are possible using adaptive statistical methods. These methods were used to describe individual-subject adherence patterns for MEMS data from a clinical trial. Subjects were adaptively clustered into groups with similar adherence patterns and clusters were compared on a variety of subject characteristics. There were seven different adherence clusters: consistently high, consistently moderately high, consistently moderate, consistently moderately low, consistently low, deteriorating starting early, and deteriorating late. Compared to other subjects, subjects with consistently high and consistently moderately high adherence were more likely to be male, White, and older and to maintain during study participation a CD4 cell count over 500 and an HIV viral load of at most 400 copies/ml. These results demonstrate the effectiveness of adaptive methods for comprehensive analysis of MEMS data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107587      PMCID: PMC3155184          DOI: 10.1007/s10461-008-9512-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  19 in total

1.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

2.  Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.

Authors:  Edward M Gardner; Shweta Sharma; Grace Peng; Katherine Huppler Hullsiek; William J Burman; Rodger D Macarthur; Margaret Chesney; Edward E Telzak; Gerald Friedland; Sharon B Mannheimer
Journal:  AIDS       Date:  2008-01-02       Impact factor: 4.177

3.  Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

Authors:  Honghu Liu; Loren G Miller; Ron D Hays; Carol E Golin; Tongtong Wu; Neil S Wenger; Andrew H Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

4.  HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.

Authors:  Jonathan Shuter; Julie A Sarlo; Tina J Kanmaz; Richard A Rode; Barry S Zingman
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

5.  Factor analysis model evaluation through likelihood cross-validation.

Authors:  George J Knafl; Margaret Grey
Journal:  Stat Methods Med Res       Date:  2007-04       Impact factor: 3.021

6.  Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.

Authors:  Thomas J Podsadecki; Bernard C Vrijens; Eric P Tousset; Richard A Rode; George J Hanna
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

7.  Medication adherence patterns in adult renal transplant recipients.

Authors:  Cynthia L Russell; Vicki S Conn; Catherine Ashbaugh; Richard Madsen; Karen Hayes; Gilbert Ross
Journal:  Res Nurs Health       Date:  2006-12       Impact factor: 2.228

8.  Testing a nurse-tailored HIV medication adherence intervention.

Authors:  William L Holzemer; Suzanne Bakken; Carmen J Portillo; Richard Grimes; Jennifer Welch; Dean Wantland; Joseph T Mullan
Journal:  Nurs Res       Date:  2006 May-Jun       Impact factor: 2.381

9.  Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program.

Authors:  Jeonghoon Ahn; Jeffrey S McCombs; Changun Jung; Tim J Croudace; David McDonnell; Haya Ascher-Svanum; Eric T Edgell; Lizheng Shi
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

10.  Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.

Authors:  Philip P Gerbino; Omar Shoheiber
Journal:  Am J Health Syst Pharm       Date:  2007-06       Impact factor: 2.637

View more
  13 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

Review 2.  Advancing the Science and Practice of Medication Adherence.

Authors:  Michael J Stirratt; Jeffrey R Curtis; Maria I Danila; Richard Hansen; Michael J Miller; C Ann Gakumo
Journal:  J Gen Intern Med       Date:  2018-02       Impact factor: 5.128

3.  Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".

Authors:  Christopher J Gill; Mary Bachman DeSilva; Davidson H Hamer; Xu Keyi; Ira B Wilson; Lora Sabin
Journal:  AIDS Behav       Date:  2015-11

4.  Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study.

Authors:  Alexander Kintu; Susan E Hankinson; Raji Balasubramanian; Karen Ertel; Elioda Tumwesigye; David R Bangsberg; Jessica E Haberer
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 5.  Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.

Authors:  Eugenia M Gurvich; George A Kenna; Lorenzo Leggio
Journal:  Alcohol Alcohol       Date:  2013-08-17       Impact factor: 2.826

6.  Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa.

Authors:  Karl Peltzer; Natalie Friend-du Preez; Shandir Ramlagan; Jane Anderson
Journal:  BMC Public Health       Date:  2010-03-05       Impact factor: 3.295

7.  Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.

Authors:  Raquel B De Boni; Lu Zheng; Susan L Rosenkranz; Xin Sun; Jeffrey Lavenberg; Sandra W Cardoso; Beatriz Grinsztejn; Alberto La Rosa; Samuel Pierre; Patrice Severe; Susan E Cohn; Ann C Collier; Robert Gross
Journal:  Drug Alcohol Depend       Date:  2015-12-24       Impact factor: 4.492

8.  Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans.

Authors:  George J Knafl; Antoinette Schoenthaler; Gbenga Ogedegbe
Journal:  Patient Prefer Adherence       Date:  2012-03-22       Impact factor: 2.711

9.  Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions.

Authors:  Corrine I Voils; Heather A King; Brian Neelon; Rick H Hoyle; Bryce B Reeve; Matthew L Maciejewski; William S Yancy
Journal:  Patient Prefer Adherence       Date:  2014-05-07       Impact factor: 2.711

Review 10.  Socioeconomic factors in adherence to HIV therapy in low- and middle-income countries.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  J Health Popul Nutr       Date:  2013-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.